Epicatechin (the dominant cocoa flavanol) works through: (1) eNOS activation — directly stimulates endothelial nitric oxide synthase, increasing NO production by 30-40%, causing vasodilation and blood pressure reduction; (2) endothelin-1 suppression — reduces the vasoconstrictor signal; (3) antiplatelet activity — reduces thromboxane A2 synthesis and platelet aggregation; (4) insulin sensitivity — epicatechin activates insulin receptor substrate 1 (IRS-1) and GLUT4 translocation; (5) cerebral blood flow — NO-mediated vasodilation specifically in brain microvessels increases hippocampal perfusion. The cardiovascular mechanism is pharmacologically robust — cocoa flavanols produce a sustained, dose-dependent NO increase that explains the consistent BP reduction across 20+ trials.
No critical interactions identified.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.